dronabinol has been researched along with Gastric Ulcer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arendsen, D; Dodge, P; Dren, A; Dunnigan, D; Hallas, R; Hwang, K; Kyncl, J; Lee, YH; Plotnikoff, N; Winn, M; Young, P; Zaugg, H | 1 |
| Abdullah, R; Cravatt, BF; Kinsey, SG; Lichtman, AH; Ramesh, D; Selley, DE; Wise, LE | 1 |
| Dajani, EZ; Dajani, NE; Dayton, MT; Larsen, KR; Mir, GN; Neeleman, SD; Shahwan, TG; Taylor, J; Taylor, MS | 1 |
| Diamantis, W; Edelson, J; Sofia, RD | 1 |
4 other study(ies) available for dronabinol and Gastric Ulcer
| Article | Year |
|---|---|
Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains.
Topics: Aggression; Analgesics; Animals; Anticonvulsants; Antidepressive Agents; Antidiarrheals; Antihypertensive Agents; Ataxia; Blood Pressure; Cannabis; Cats; Dogs; Dronabinol; Gastric Mucosa; Haplorhini; Humans; Hypnotics and Sedatives; Male; Mice; Motor Activity; Rats; Sleep; Stomach Ulcer; Structure-Activity Relationship; Tranquilizing Agents | 1976 |
Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arachidonic Acids; Benzodioxoles; Brain Chemistry; Cyclohexanols; Diclofenac; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Endocannabinoids; Glycerides; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mice; Mice, Inbred C57BL; Monoacylglycerol Lipases; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stomach Ulcer; Substance Withdrawal Syndrome; Substance-Related Disorders | 2013 |
1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.
Topics: Administration, Oral; Analgesia; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cannabinoids; Carcinoma, Basal Cell; Dimethyl Sulfoxide; Dronabinol; Drug Interactions; Indomethacin; Injections, Intraperitoneal; Male; Mice; Pain Measurement; Rats; Rats, Wistar; Stomach Ulcer | 1999 |
Effect of delta9-tetrahydrocannabinol on the gastrointestinal tract of the rat.
Topics: Animals; Aspirin; Digestive System; Dronabinol; Erythrocytes; Fasting; Feces; Gastric Mucosa; Male; Rats; Stomach Ulcer | 1978 |